EUVIMEDEUVIMED entdecken
Crossref

Mesenchymal Stem Cells in High-Grade Serous Ovarian Cancer: Dual Roles in Tumor Progression and Therapeutic Potential

Sambasivam Gopinath, Pavithra Balakrishnan, Yamini Muli, Sabrin S, Pratheesha Rajathi Vijaykumar, Saranya Puniyakotti, Nithya Varadarajan

International Journal of Drug Delivery Technology · 18.06.2026 · 16 (55s)

DOI: 10.25258/ijddt.16.55s.151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.06.2026. Verfasst von Sambasivam Gopinath und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the most dangerous form of epithelial ovarian cancer, high-grade serous ovarian cancer (HGSC) spreads quickly, responds poorly to treatment, and offers limited choices for patients. Some recent studies have shown that mesenchymal stem cells (MSCs) play key roles in the tumor microenvironment of HGSC and demonstrate both helpful and detrimental effects. On the one hand, it helps the growth of tumors by supporting their ability to avoid the immune system, change in structure, develop new blood vessels, and keep cancer stem cells alive, which leads to platinum resistance and relapse. On a different note, their preference for tumors, minimal reaction by the immune system, and easy genetic manipulation make them good for targeted treatments, including both engineered cytokine and prodrug technology. This review covers how MSCs and HGSC cells interact, reviews possible ways HGSCs evade therapy through mitochondrial transfer and reprogramming the stroma, and looks at the benefits and potential dangers involved in MSC treatments. Combining data from preclinical studies with new translational techniques, we stress how observing the functions of MSC subsets carefully can benefit treatment while limiting their risk of helping cancer growth. The use of MSCs in HGSC brings both difficulties and potential benefits to developing precision treatments.

Zitieren

APA

Gopinath, S., Balakrishnan, P., Muli, Y., S, S., Vijaykumar, P. R., Puniyakotti, S., & Varadarajan, N. (2026). Mesenchymal Stem Cells in High-Grade Serous Ovarian Cancer: Dual Roles in Tumor Progression and Therapeutic Potential. International Journal of Drug Delivery Technology, 16(55s). https://doi.org/10.25258/ijddt.16.55s.151

Vancouver

Gopinath S, Balakrishnan P, Muli Y, S S, Vijaykumar PR, Puniyakotti S, et al. Mesenchymal Stem Cells in High-Grade Serous Ovarian Cancer: Dual Roles in Tumor Progression and Therapeutic Potential. International Journal of Drug Delivery Technology. 2026;16(55s). doi:10.25258/ijddt.16.55s.151

BibTeX
@article{Gopinath2026,
  author = {Gopinath, Sambasivam and Balakrishnan, Pavithra and Muli, Yamini and S, Sabrin and Vijaykumar, Pratheesha Rajathi and Puniyakotti, Saranya and Varadarajan, Nithya},
  title = {Mesenchymal Stem Cells in High-Grade Serous Ovarian Cancer: Dual Roles in Tumor Progression and Therapeutic Potential},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {55s},
  doi = {10.25258/ijddt.16.55s.151}
}
Kostenlos starten →